Clinical Trials in Detroit

Showing 10941-10960 of 16,931 trials

Open-label Extension Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

NCT02613182

The rationale for this study is to provide additional treatment with NEOD001 for subjects who complete Study NEOD001-001, and to continue to evaluate long term safety and tolerability. All subjects in the current NEOD001 trials are being dosed at 24 mg/kg, which will be continued in this study.

AL Amyloidosis

Prothena Biosciences Ltd.34 participantsStarted Feb 2016

Stanford, California, United States • Boston, Massachusetts, United States • Detroit, Michigan, United States +2 more locations

COMPLETEDPhase 1< 1 mile

Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer

NCT01597193

The purpose of this study is to determine the safety, tolerability and pharmacokinetics of enzalutamide alone and in combination with anastrozole, or exemestane, or fulvestrant in patients with incurable breast cancer.

Breast Cancer

Pfizer101 participantsStarted Apr 2012

Aurora, Colorado, United States • Aurora, Colorado, United States • Aurora, Colorado, United States +14 more locations

Open-label Extension Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer

Find Trials by Condition in Detroit

Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction

SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)

EIT Assessment of Lung Volume and Tidal Distribution: A Comparison of Non-Invasive Ventilation Devices

Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis

ST266 Versus Standard Care In Treating Partial Thickness Burns

A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents

BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)

A 6-month Clinical Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With T2DM

Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone

AG-013736 In Combination With Gemcitabine Versus Gemcitabine Alone For Patients With Metastatic Pancreatic Cancer

A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy

Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia

A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

A Study for Patients With Acute Leukemia

A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma

Fenzian Asthma Multicenter Outcomes Study

Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder